Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-30
DOI
10.3389/fonc.2022.855674
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis
- (2021) Zhengyu Fang et al. World Journal of Surgical Oncology
- A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients
- (2021) Xing Wei et al. Scientific Reports
- SEZ6L2 knockdown impairs tumour growth by promoting caspase‐dependent apoptosis in colorectal cancer
- (2020) Ning An et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
- (2020) Pan Xie et al. CELLULAR ONCOLOGY
- 5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
- (2020) Sabrina Blondy et al. CANCER SCIENCE
- Organoids — Preclinical Models of Human Disease
- (2019) Mo Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- TGF-β1 protects colon tumor cells from apoptosis through�XAF1 suppression
- (2019) Jung Rock Moon et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor Mutation Burden and Prognosis in Colorectal Cancer Patients Treated with Adjuvant Fluoropyrimidine and Oxaliplatin
- (2019) Dae-Won Lee et al. CLINICAL CANCER RESEARCH
- Biomarker-guided therapy for colorectal cancer: strength in complexity
- (2019) Anita Sveen et al. Nature Reviews Clinical Oncology
- Translational genomics and precision medicine: Moving from the lab to the clinic
- (2019) Eleftheria Zeggini et al. SCIENCE
- Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
- (2019) Ye Yao et al. Cell Stem Cell
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- A rectal cancer organoid platform to study individual responses to chemoradiation
- (2019) Karuna Ganesh et al. NATURE MEDICINE
- 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
- (2019) Sona Vodenkova et al. PHARMACOLOGY & THERAPEUTICS
- Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
- (2019) Mimmo Turano et al. Cancers
- Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer
- (2018) Kai Song et al. CANCER SCIENCE
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- How many differentially expressed genes: A perspective from the comparison of genotypic and phenotypic distances
- (2018) Bi Zhao et al. GENOMICS
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
- (2018) Hervé Tiriac et al. Cancer Discovery
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
- (2017) Laura Broutier et al. NATURE MEDICINE
- Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- (2017) Chantal Pauli et al. Cancer Discovery
- A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
- (2016) Masayuki Fujii et al. Cell Stem Cell
- Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis
- (2016) Kenji Kawai et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer
- (2016) Teng Wang et al. ONCOLOGY REPORTS
- Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data
- (2016) Ida Kappel Buhl et al. PLoS One
- DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?
- (2016) E. E. Voest et al. Cancer Discovery
- The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care
- (2016) Marina De Rosa et al. Therapeutic Advances in Gastroenterology
- Identification and Construction of Combinatory Cancer Hallmark–Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer
- (2016) Shanwu Gao et al. JAMA Oncology
- Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells
- (2015) Min-Jung Kim et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
- (2015) Marc van de Wetering et al. CELL
- Building the foundation for genomics in precision medicine
- (2015) Samuel J. Aronson et al. NATURE
- TP53 loss creates therapeutic vulnerability in colorectal cancer
- (2015) Yunhua Liu et al. NATURE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- Genetics, diagnosis and management of colorectal cancer (Review)
- (2015) MARINA DE ROSA et al. ONCOLOGY REPORTS
- Overcoming 5-Fu Resistance of Colon Cells through Inhibition of Glut1 by the Specific Inhibitor WZB117
- (2014) Wei Liu et al. Asian Pacific Journal of Cancer Prevention
- Comparison of Tumor Regression Grade Systems for Locally Advanced Rectal Cancer After Multimodality Treatment
- (2014) Atthaphorn Trakarnsanga et al. JNCI-Journal of the National Cancer Institute
- Gene signatures of drug resistance predict patient survival in colorectal cancer
- (2014) Y Zheng et al. PHARMACOGENOMICS JOURNAL
- Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients
- (2013) P A Candy et al. BRITISH JOURNAL OF CANCER
- Colon and Rectal Cancer Survival by Tumor Location and Microsatellite Instability
- (2013) Amanda I. Phipps et al. DISEASES OF THE COLON & RECTUM
- Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
- (2012) Ralf-Dieter Hofheinz et al. LANCET ONCOLOGY
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review
- (2012) Rebeca Sanz-Pamplona et al. PLoS One
- Target Gene Analysis by Microarrays and Chromatin Immunoprecipitation Identifies HEY Proteins as Highly Redundant bHLH Repressors
- (2012) Julia Heisig et al. PLoS Genetics
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
- (2010) Ramon Salazar et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now